GSK Investigational Site

Bad Berka 99437

0 studies enrolling now · 1 studies all time

What they study most

Lung Cancer, Non-Small Cell

Studies at this site

• Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy — Running, not enrolling